Michael Obadia
Michael Obadia is an expert in Neurology at Hôpital Fondation Adolphe de Rothschild (France). As of September 2026, ScienceLeadR ranks Michael Obadia in the top 1% of experts worldwide for Brain Ischemia and Cerebrovascular Disorders. Michael Obadia has authored 243 publications, the most recent in 2026, and is an investigator in 34 clinical trials, 5 of them ongoing. SLR score: 776 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Cardiology - Surgery - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2026
Number : 243
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 34
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 21
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Phase 3 Placebo controlled Study of Milvexian after an Acute Ischemic Stroke or High Risk Transient Ischemic Attack 2022-501176-26-00 — safety, ischemic stroke, stroke, ischemic attack, transient, factor xia, factor xia inhibitor | Phase 3 | Active not recruiting | 2023 |
| Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke A Multicenter Randomized Controlled Trial (IVT ALL IN) NCT07603440 — brain infarction, ischemic stroke, stroke, plasminogen, plasminogen activators, tissue plasminogen activator, administration, intravenous, brain, vascular diseases, reperfusion, cerebrovascular disorders, brain ischemia, tenecteplase, therapeutics, cerebral infarction, thrombectomy, ischemia | Phase 3 | Not yet recruiting | 2026 |
| Acute Stroke Prehospital Versus In HospitAL Initiation of Recanalization Therapy ASPHALT NCT05649670 — ischemic stroke, stroke, emergencies, triage, ambulances, angiography, reperfusion, therapeutics, thrombectomy, emergency medical services, computed tomography angiography | N/A | Recruiting | 2023 |
| Tenecteplase Treatment in Ischemic Stroke Registry NCT05534360 — registries, ischemic stroke, stroke, brain, cardiovascular diseases, thrombolytic therapy, vascular diseases, brain diseases, cerebrovascular disorders, tenecteplase, therapeutics, nervous system, nervous system diseases, thrombectomy | N/A | Not yet recruiting | 2022 |
| PFO Closure Oral Anticoagulants or Antiplatelet Therapy After PFO associated Stroke in Patients Aged 60 to 80 Years NCT05387954 — anticoagulants, foramen ovale, patent, ischemic stroke, stroke, rivaroxaban, clopidogrel, aneurysm, aspirin, cardiology, aged, factor xa inhibitors, therapeutics, factor xa, dabigatran, foramen ovale, apixaban | Phase 3 | Recruiting | 2023 |
LeadR Networks
Main global connection map